GetTopicDetailResponse(id=cebd12e313b2, topicName=治療性癌癥疫苗, introduction=, content=新抗原 治療性癌癥疫苗, image=null, comments=0, allHits=192, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue May 27 10:12:14 CST 2025, time=2025-05-27, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103842, tagList=[TagDto(tagId=103842, tagName=治療性癌癥疫苗)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2266822, encodeId=82102266822e2, content=<a href='/topic/show?id=9d2d583695c' target=_blank style='color:#2F92EE;'>#新抗原#</a> <a href='/topic/show?id=cebd12e313b2' target=_blank style='color:#2F92EE;'>#治療性癌癥疫苗#</a>, objectTitle=治療性癌癥疫苗的突破與未來(lái)展望, objectType=article, longId=878591, objectId=d9468e85918f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=d9468e85918f, replyNumber=0, likeNumber=32, createdTime=2025-05-27, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d9468e85918f, moduleTitle=治療性癌癥疫苗的突破與未來(lái)展望, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d9468e85918f)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-27發(fā)表于上海
